Skip to main content

Ready to start planning your care? Call us at 800-525-2225 to make an appointment.

Memorial Sloan Kettering Cancer Center
  • Sloan Kettering Institute
  • Research
      • Changing how the world understands and treats cancer

        Our scientists pursue every aspect of cancer research—from exploring the biology of genes and cells, to developing immune-based treatments, uncovering the causes of metastasis, and more.

      • Programs & Centers
      • Sloan Kettering Institute
        Pursuing basic and translational research across 9 programs and 100+ labs
      • Memorial Hospital research
        Focusing on clinical cancer research and population health
      • Human Oncology & Pathogenesis Program (HOPP)
        Bridging the lab and the clinic through translational research
      • Collaborative research centers
        Fostering interdisciplinary collaborations between laboratory scientists and clinicians
      • Extramural collaborations
        Partnering with other academic and research institutions
      • Research at MSK
      • Our research impact
      • Research topics
      • Core facilities & resources
        Offering state-of-the-art resources for our researchers
      • Find a researcher or lab
      • Education & training programs
      • MSK Innovation
      • MSK Commercialization Ecosystem
        Partnering, new ventures, and business accelerators
      • Clinical Trial Innovation
        Incubating and implementing better ways to run clinical trials
      • Our Innovation Story
        Showcasing key developments and achievements
  • Education & Training
      • Training the next generation of clinicians and scientists

        Our highly-specialized educational programs shape leaders to be at the forefront of cancer care and research.

      • For Healthcare
      • Graduate medical education (GME)
      • Medical student opportunities
      • Continuing medical education (CME)
      • Continuing nursing education (CNE)
      • Academic departments & divisions
      • Explore all programs
      • For Research
      • Postdoctoral training
      • Gerstner Sloan Kettering Graduate School of Biomedical Sciences
      • PhD & MD/PhD programs
      • Explore all programs
  • Careers
  • MSK Direct
  • Locations & Language

    In the U.S.

    • English
    • Español
    • Pусский

    Outside of the U.S.

    • العَرَبِيَّة
    • Deutsch
    • English
    • Español
    • 한국어
    • עִבְרִית
    • Italiano
    • Portugês
    • Pу́сский
    • Türkçe
    • 中文
  • Make an Appointment
    Back
    Make an Appointment
      • We're here for you.

        Make an appointment

        New patient
        Current patient

        Speak to a care advisor

        Adults: 800-525-2225

        Available 24 hours a day, 7 days a week

        Children & Teens: 833-MSK-KIDS

        Monday through Friday, 9 a.m. to 5:30 p.m. (Eastern time)

      • Becoming A Patient
      • Why choose MSK
      • How to become a patient
      • Insurance & financial assistance
      • Preparing for your first appointment
      • Meet our doctors
      • Explore our locations
  • Learn About Cancer & Treatment
    Back
    Learn About Cancer & Treatment
      • We treat every type of cancer, including the most important one: yours.

        With cancer, where you get treated first matters. From diagnosis to treatment, our experts provide the care and support you need, when you need it.

      • Adults
      • Cancers & conditions
      • Risk assessment & screening
      • Diagnosis & treatment
      • Clinical trials
      • Children & Teens
      • Cancers & conditions
      • Diagnosis & treatment
      • Clinical trials
      • Support, Services & Programs
      • For adults
      • For children & teens
      • For caregivers
      • Adolescents & young adult (AYA) program
      • Patient & caregiver education library
      • Cancer News & Discoveries
      • Read the latest
      • Sign up for our newsletter
  • For Physicians
    Back
    For Physicians
      • Partner with us to treat your patient’s cancer.

        Refer a patient

        CALL OUR DEDICATED CLINICIAN ACCESS NUMBER

        646-677-7440

        Monday through Friday, 8 a.m. to 6 p.m. (Eastern time)

      • Clinical Resources
      • Our doctors
      • Physician relations
      • Clinical updates & insights
      • Prediction tools
      • Clinical trials
      • Continuing medical education (CME)
  • About Us
    Back
    About Us
      • Our mission: Ending cancer for life.

        Memorial Sloan Kettering was founded in 1884, and today is a world leader in patient care, research, and educational programs.

      • About Us
      • Our mission, vision & core values
      • Leadership
      • History
      • Inclusion & belonging
      • Annual report
      • Give to MSK
      • For the Media
      • Media inquiries
      • Press Releases
      • Newsroom
      • Have Questions?
      • Contact us
      • Plan Your Visit
      • Explore our locations
      • Directions
      • Visitor policy
  • MSK MyChart
  • Donate Now
    • Sloan Kettering Institute
    • Research
      Back
      Research
        • Programs & Centers
        • Sloan Kettering Institute
          Pursuing basic and translational research across 9 programs and 100+ labs
        • Memorial Hospital research
          Focusing on clinical cancer research and population health
        • Human Oncology & Pathogenesis Program (HOPP)
          Bridging the lab and the clinic through translational research
        • Collaborative research centers
          Fostering interdisciplinary collaborations between laboratory scientists and clinicians
        • Extramural collaborations
          Partnering with other academic and research institutions
        • Research at MSK
        • Our research impact
        • Research topics
        • Core facilities & resources
          Offering state-of-the-art resources for our researchers
        • Find a researcher or lab
        • Education & training programs
        • MSK Innovation
        • MSK Commercialization Ecosystem
          Partnering, new ventures, and business accelerators
        • Clinical Trial Innovation
          Incubating and implementing better ways to run clinical trials
        • Our Innovation Story
          Showcasing key developments and achievements
    • Education & Training
      Back
      Education & Training
        • For Healthcare
        • Graduate medical education (GME)
        • Medical student opportunities
        • Continuing medical education (CME)
        • Continuing nursing education (CNE)
        • Academic departments & divisions
        • Explore all programs
        • For Research
        • Postdoctoral training
        • Gerstner Sloan Kettering Graduate School of Biomedical Sciences
        • PhD & MD/PhD programs
        • Explore all programs
    • Careers
    • MSK Direct
    • Locations & Language
      Back
      Locations & Language

      In the U.S.

      • English
      • Español
      • Pусский

      Outside of the U.S.

      • العَرَبِيَّة
      • Deutsch
      • English
      • Español
      • 한국어
      • עִבְרִית
      • Italiano
      • Portugês
      • Pу́сский
      • Türkçe
      • 中文
  • Precision Interception and Prevention (PIP) Program

Research Initiatives

Precision Interception and Prevention (PIP) Program
More About Precision Interception and Prevention (PIP) Program
Mission and Scope
Research Initiatives
  • Overview
  • Clonal Hematopoiesis Risk
  • Inherited Cancer Risk (Cancer Genetics)
  • High Risk for Cancer Recurrence
  • High Risk Tobacco-Related Cancers
  • High-Risk for HPV-Related Cancers
  • Digital Outreach
Leadership and Administration
Contact Information
Events
  • Overview
  • Past Events

Research Initiatives

Share
Share

Since its launch, PIP has been successful in developing and accelerating efforts across the cancer prevention and detection research continuum. Listed below are PIP’s projects.

  • Clonal Hematopoiesis Risk
  • Inherited Cancer Risk (Cancer Genetics)
  • High Risk for Cancer Recurrence
  • High Risk Tobacco-Related Cancers
  • High-Risk for HPV-Related Cancers
  • Digital Outreach

Book traversal links for Precision Interception and Prevention (PIP) Program

Previous

Mission and Scope

Next

Clonal Hematopoiesis Risk
Related topics:
Physician-scientist Ross Levine and research technician Aishwarya Krishnan speak in the lab
MSK Opens New Clinic to Monitor People with a Genetic Risk for Developing Blood Cancer
FDA Expands Use of HPV Vaccine: What It Means in the Fight against Cancer
  • Connect
    • Contact us
    • Locations
    • Appointments
      800-525-2225
      • Instagram
      • Facebook
      • X
      • YouTube
      • Linkedin
  • About MSK
    • About us
    • Careers
    • Giving
  • Cancer Care
    • Adult cancer types
    • Child & teen cancer types
    • Integrative medicine
    • Nutrition & cancer
    • Find a doctor
  • Research & Education
    • Sloan Kettering Institute
    • Gerstner Sloan Kettering Graduate School
    • Graduate medical education
    • MSK Library
Memorial Sloan Kettering Cancer Center
  • Communication preferences
  • Cookie preferences
  • Legal disclaimer
  • Accessibility statement
  • Privacy policy
  • Price transparency
  • Public notices
© 2025 Memorial Sloan Kettering Cancer Center
  • Log in staging-45011.prod.hosting.acquia.com